Polymerase chain reaction–based restriction fragment length polymorphism analysis of the short arm of chromosome 3 in primary head and neck squamous carcinoma

Cancer

Volumn 72, Issue 3, 1993, Pages 881-886

  El‐Naggar, Adel K ^a   Lee, Ming‐Sheng ^a   Wang, Gang ^a   Luna, Mario A ^a   Goepfert, Helmuth ^b   Batsakis, John G ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

flow cytometry; head and neck squamous carcinoma; loss of heterzygosity; polymerase chain reaction; restriction fragment length polymorphism; short arm of chromosome 3

Indexed keywords

ARTICLE; CANCER GENETICS; CHROMOSOME 3; CHROMOSOME DELETION; CLINICAL ARTICLE; GENETIC POLYMORPHISM; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT; SUPPRESSOR GENE;

AGED; AGED, 80 AND OVER; BASE SEQUENCE; BLOTTING, SOUTHERN; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; DNA, NEOPLASM; FEMALE; HEAD AND NECK NEOPLASMS; HETEROZYGOTE; HUMAN; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; MUCOUS MEMBRANE; OLIGODEOXYRIBONUCLEOTIDES; PLOIDIES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0027177767     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19930801)72:3<881::AID-CNCR2820720337>3.0.CO;2-Q     Document Type: Article

References (43)

1. Experimental head and neck oncology
2. Pathology of squamous carcinomas of the head and neck
3. Prognostic variables in head and neck cancer: tumor site, stage, nodal status, differentiation, and immune status
4. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx and esophagus in Northern Italy
5. Numerical chromosome aberrations in human neoplasia
6. The chromosomal analysis of human solid tumors: a triple challenge
7. The cytogenetics of solid tumors: relation to diagnosis, classification and pathology
8. Cytogenetics of epithelial malignant lesions
9. Cellular oncogenes in neoplasia
10. Cancer genes: current status, future prospects, and applications in radiotherapy oncology
11. Oncogene amplification in neoplastic development and progression of human cancers
12. Molecular biology in the diagnosis and prognosis of solid and lymphoid tumor
13. Cytogenetic studies of eight squamous cell carcinomas of the head and neck: deletion of 7, a possible primary chromosomal event
14. Cytogenetic analysis of head and neck carcinomas
15. Comparative chromosome analysis of nine squamous cell carcinoma cell lines from tumor of the head and neck
16. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck
17. Biology, cytogenetics, sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines
18. Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas
19. Unique karyotypic abnormalities in a squamous cell carcinoma of the larynx
20. Frequent rearrangement of chromosomal bands 1p22 and 11q13 in squamous cell carcinoma of the head and neck
21. Consistent chromosome changes in 15 squamous cell carcinomas of the head and neck
22. The polymerase chain reaction: its use in the molecular characterization and diagnosis of cancers
23. Molecular analysis of the short arm of chromosome 3 in small cell and non‐small‐cell carcinoma of the lung
24. An unusually proximal deletion on the short arm of chromosome 3 in a patient with small cell lung cancer
25. Frequency and extent of allelic loss in the short arm of chromosome 3 in non‐small‐cell lung cancer
26. Loss of heterozygosity on chromosome 3, 13, and 17 in small‐cell carcinoma and on chromosome 3 in adenocarcinoma of the lung
27. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix
28. The region of common allelic losses in sporadic renal cell carcinoma is bordered by the loci D3S2 and THRB
29. Deletion mapping in human renal cell carcinoma
30. A gene near the D3F15S2 site on 3p is expressed in normal kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC)
31. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma
32. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma
33. Chromosome 3p deletions in head and neck carcinomas: statistical ascertainment of allelic loss
34. Histological typing of upper respiratory tract tumors
35. Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in a flow cytofluorometric system
36. A technique for radio‐labelling DNA restriction endonuclease fragments to high specific activity
37. A review of the evidence for tumor suppressor genes
38. Ordering of six polymorphic DNA markers important in the delineation of 3p deletions in neoplasia
39. Detection of loss of heterozygosity in tumor DNA samples by PCR
40. PCR‐based RFLP analysis allows genotyping of the short arm of chromosome 3 in small biopsies from patients with lung cancer
41. Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumor with high proliferation index
42. K‐ras point mutations in human colorectal carcinomas: relation to aneuploidy and metastasis
43. Genetic alterations within the retinoblastoma locus in colorectal carcinomas: relation to DNA ploidy studied by flow cytometric analysis